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: Vitamin D deficiency has been associated with several
tcomes mainly in the outpatient setting. The objective of this
to examine the prevalence of vitamin D deficiency and its
n with risk of adverse clinical outcomes in a large prospective
medical inpatients.
llected clinical data and measured 25(OH)D levels in adult
atients upon hospital admission and followed them for 30
ression analyses adjusted for age, gender, comorbidities, and
ical diagnosis were performed to study the effect of vitamin D
on several hospital outcomes.
7 included patients, 1510 (35.47%) had 25(OH)D levels of 25
l/L (vitamin D insufficiency) and 797 (18.72%) had levels of
L (severe deficiency). Vitamin D insufficiency and severe
were associated (OR/HR, 95%CI) with an increased risk of
ortality (OR 1.70, 1.22–2.36 and 2.70, 1.22–2.36) and
length of stay (HR 0.88, 0.81–0.97 and 0.72, 0.65–0.81).
ficiency was associated with risk of falls (OR 1.77, 1.18–
aired Barthel index (OR 1.80, 1.42–2.28), and impairment in
life. Most associations remained robust after multivariate
t and in subgroups stratified by gender, age, comorbidities,
diagnoses (P for interaction >0.05).
comprehensive and large medical inpatient cohort, vitamin D
was highly prevalent and strongly associated with adverse
tcome. Interventional research is urgently needed to prove the























Philipp Schuetz, MD, MPH
CI = confidence interval, COPD = chronic obstructive
ry disease, LOS = length of hospital stay, OR = odds ratio.
INTRODUCTION
ans, vitamin D is acquired from transformation of
drocholesterol in the epidermis by exposure to ultra-
adiation, as well as dietary intake. The vitamin is then
zed in the liver to 25-hydroxyvitamin D (25(OH)D)
he kidneys to the active 1,25-dihydroxyvitamin D
)2D). It has pleiotropic effects since a majority
in the human body express vitamin D receptors.
)2Dmay interactwithover200genes thereby influencing
proliferation, differentiation, apoptosis, angiogenesis,
d renin production, bone and muscle metabolism, and
gmacrophagecathelicidinproduction.1–4 Inaccordance
e cellular effects, several clinical studies reported nega-
ts of vitamin D deficiency on mortality risk,5–8 cancer,9
cular,10 and infectious diseases11–13 among others.
ough there is still controversy about optimal levels of
D, a 25(OH)D serum concentration of less than
L is generally considered to indicate vitamin D insuf-
ith levels of<25nmol/L indicating severe deficiency.
a sufficient vitamin D status is mostly defined by its
for the prevention of bone diseases. Optimal levels,
may also depend on the patient population and
illness with recent evidence suggesting that higher
to 75–110 nmol/L) may positively influence medical
such as cancer or cardiovascular diseases.14–18
vitamin D deficiency is increasingly being prevalent
e19 with a prevalence of about 50% in the healthy
opulation in Switzerland20 in-depth knowledge of this
ing factor to disease has important public health implica-
ost of this research, however, has focused onoutpatients
cal data on medical inhospital patients are still scarce.
lose this gap, the aim of this prospective patient cohort
s to examine the associations of vitamin D deficiency




is an observational, prospective cohort study. Between
013 and February 2014 consecutive adult medical
were included upon hospital admission in the emer-lity-control TRIAGE project.






















































































































2 | wwn observational quality control study, the Institutional
oard of the Canton of Aargau has approved the study




. Initial vital signs and other clinical information such as
ographics, main medical diagnosis, and comorbidities
rded upon admission. Left over blood samples of all
ere collected and stored for later analyses including
ent of vitaminD levels.Clinical information andpatient
were assessed until hospital discharge and all patients
tacted by a structured phone interview 30 days after
in order to evaluate satisfaction with care, clinical and
l outcome measures, quality of life measures, perform-
tivities of daily living, as well as rehospitalization rates
ality. In case the patient could not be reached, family
or the general practitioner were contacted.22
iagnosis and Comorbidities
ents were divided according to their leading diagnosis
infections, cardiovascular diseases, metabolic dis-
ncer, neurological disorders, digestive tract diseases,
ry diseases, and other disease. Metabolic diseases
ncluded different diseases such as diabetes with hypo-
or hyperglycemia, hyperlipidemia, and severe electro-
rbances among others. We also defined the following
ity groups: congestive heart failure, chronic obstruc-
onary disease, dementia, diabetes mellitus, cancer, and
enal failure. Nutritional status was assessed using the
al Risk Screening 2002 within 48 hours after hospital
n. A risk of malnutrition was defined as a Nutritional
eening 2002 score of 3 points.23
e
primary outcome was 30 day all-cause mortality
during the hospital stay and by telephone interviews
.
ndary outcomes included functional impairment,
f life, length of hospital stay (LOS), readmission rate,
and fractures. Performance of daily living was
by the Barthel index.24 We defined functional impair-
Barthel index< 95 points. In order to assess quality of
sed the standardized measure of health questionnaire
including a descriptive system with 5 dimensions
, self-care, usual activities, pain/discomfort, and
epression), as well as a Europe specific summary
ue.25 These results were displayed as 2 levels, ‘‘impair-
or ‘‘no impairments.’’ The occurrence of falls and
was registered during hospitalization and in the 30
owing hospitalization by telephone interview.
ent of Vitamin D Levels and Definition of
iency
H)D levels were measured on left-over samples upon
n using a chemiluminescence immunoassay for the
ve determination of vitamin D. This method determines

























































alserum 25(OH)D> 50nmol/L (>20ng/mL), vitamin D
ncy as 25 to 50 nmol/L (10–20ng/mL), and a severe





gorical variables are expressed as percentages and
r vice versa and continuous variables as medians
rtile ranges, 25th–75th percentiles), unless stated
. Frequency comparison was done by the Chi-square
all binary endpoints logistic models with odds ratios
d 95% confidence intervals (95%CIs) were used. For
ospital discharge, Cox regression models with hazard
re calculated. To adjust for possible confounding we
atistical models: model 1 for age and gender; model 2
gender, and comorbidities; model 3 for age, gender,
ities, and main diagnosis.
evaluated the association between vitamin D levels and
in the overall population as well as within different
d subgroups based on gender, age (cut-off 75 years), and
dical diagnosis. Evidence of effect modification within
groups was assessed by inclusion of interaction terms
atisticalmodels.AP value<0.05 (for a 2-sided test)was
d statistically significant. All statistical analyses were




50nmol/L (vitamin D insufficiency) and 797 (18.72%)
s of<25nmol/L (severe deficiency). Baseline character-
he overall population stratified according to vitamin D
summarized in Table 1. Patients with an inadequate
level were older and were at higher risk of malnutrition.
ry analysis in patients with low vitamin D levels revealed
rum albumin levels, lower albumin corrected serum
evels and higher serum levels of creatinine. Also, patients
luded during winter and spring season had significantly
amin D levels as compared to summer and fall.
y Endpoint: Association of Vitamin D
rtality
h lower vitamin D levels we found a stepwise increase
ity of 3.4%, 5.6%, and 8.7% in patients with vitamin D
cy, insufficiency, and severe deficiency, respectively.
sion analysis, the unadjusted OR of 30-day mortality
in D insufficient patients compared to sufficient levels
e) was 1.70 (95%CI 1.22–2.36, P¼0.002) and in
deficient patients 2.70 (1.22–2.36, P<0.001). After
adjustment for demographics (model 1), comorbidities
), and medical diagnosis (model 3), the associations
significant with an OR of 1.49 (95%CI 1.03–2.14,
) for insufficient and 1.92 (95%CI 1.29–2.14,
1) for severely deficient patients in the fully adjusted
or detailed results see Table 2).
also investigated whether the association of vitamin D
y and 30 day mortality would differ among subgroups
ent demographics and main diagnoses (Appendix 1,
s.lww.com/MD/A941 and in Figure 1). For most
results were robust and no evidence of effect modi-
(P>0.05) was found, except for neurological dis-
r which the associations became weaker.
ary Endpoints: Vitamin D and Hospital
es
Medicine  Volume 95, Number 19, May 2016was stepwise increased in vitamin D sufficient,
nt, and severely deficient patients (3 [1, 6], 4 [1, 7],
9] days, respectively, P<0.001).


























TABLE 1. Baseline Characteristics Categorized by Vitamin D Status
Characteristics Overall Normal Vitamin D Status Insufficiency Severe Deficiency P Value
N, % 4257 (100%) 1950 (45.8%) 1510 (35.5%) 797 (18.7%)
Age (median, IQR) 63 (46, 75) 61 (44, 74) 63 (46, 75) 68 (52, 79) <0.001
Male sex 2364 (55.5%) 1068 (54.8%) 869 (57.5%) 427 (53.6%) 0.12
NRS 3 378 (24.42%) 147 (22.1%) 121 (22.3%) 110 (32.4%) <0.001
Laboratory findings
Albumin (median, IQR) 37.7 (34, 40.7) 38.0 (34.6, 40.9) 37.7 (34.2, 40.5) 36.7 (31.5, 40.1) <0.001
Creatinine (median, IQR) 85 (70, 105) 84 (71, 102) 85 (69, 106) 87 (71, 117) 0.002
Calcium (median, IQR) 2.26 (2.19, 2.35) 2.26 (2.19, 2.35) 2.26 (2.18, 2.34) 2.28 (2.20, 2.37) <0.001
CRP (median, IQR) 17.9 (6.9, 70.1) 18 (7, 70) 16 (7, 62) 21 (7, 74) 0.25
Leucocytes (median, IQR) 8.5 (6.7, 11.0) 8.3 (6.7, 10.8) 8.6 (6.8, 11.1) 8.6 (6.6, 11.3) 0.34
Season
Spring 1698 (43.9%) 570 (33.5%) 724 (51.9%) 404 (52.3%) <0.001
Summer 1386 (35.8%) 849 (49.9%) 393 (28.2%) 144 (18.6%) <0.001
Fall 324 (8.4%) 180 (10.6%) 101 (7.2%) 43 (5.6%) <0.001
Winter 461 (11.9%) 101 (5.9%) 178 (12.8%) 182 (23.5%) <0.001
Main diagnosis
Infectious disease 610 (14.3%) 279 (14.3%) 204 (13.5%) 127 (15.9%) 0.29
Cardiovascular disease 947 (22.3%) 414 (21.2%) 354 (23.4%) 179 (22.5%) 0.3
Metabolic disorder 59 (1.4%) 14 (0.7%) 24 (1.6%) 21 (2.6%) <0.001
Cancer 217 (5.10%) 92 (4.7%) 85 (5.6%) 40 (5.0%) 0.48
Neurological disorder 1083 (25.44%) 525 (26.9%) 383 (25.4%) 175 (22.0%) 0.025
Digestive tract disease 458 (10.76%) 209 (10.7%) 155 (10.3%) 94 (11.8) 0.53
Pulmonary disease 157 (3.69%) 64 (3.3%) 62 (4.1%) 31 (3.9%) 0.42
Miscellaneous 726 (17.05%) 353 (18.1%) 243 (16.1%) 130 (16.3%) 0.25
Comorbidities
Diabetes 610 (14.33%) 211 (10.8%) 235 (15.6%) 164 (10.6%) <0.01
Tumor 638 (14.99%) 258 (13.2%) 235 (15.6%) 145 (18.2%) 0.003
Heart failure 250 (5.87%) 86 (4.4%) 89 (5.9%) 75 (9.4%) <0.001
COPD 204 (4.79%) 71 (3.6%) 70 (4.6%) 63 (7.9%) <0.001
Dementia 130 (3.05%) 48 (2.5%) 41 (2.7%) 41 (5.1%) <0.001
Renal failure 633 (14.87%) 225 (11.5%) 233 (15.6%) 175 (22.0%) <0.001
Obesity 520 (12.22%) 193 (9.9%) 220 (14.6%) 107 (13.4%) <0.001
Location after discharge
Home 1.645 (38.64%) 768 (39.4%) 573 (37.9%) 304 (38.1%) 0.66
Other hospital 226 (5.31%) 91 (4.7%) 83 (5.5%) 52 (6.5%) 0.13
Nursing home 172 (4.04%) 63 (3.2%) 55 (3.6%) 54 (6.8%) <0.001
Rehabilitation clinic 197 (4.63%) 87 (4.5%) 67 (4.4%) 43 (5.4%) 0.52
Inhospital death 115 (2.70%) 35 (1.8%) 51 (3.4%) 29 (3.6%) 0.003
Other or unknown 1.902 (44.68%) 906 (46.5%) 681 (45.1%) 315 (39.5%) 0.004
COPD¼ chronic obstructive pulmonary disease, CRP¼C-reactive protein, IQR¼ interquartile range, NRS¼ nutritional risk score, P¼P-value
are statist
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Copyrightdjusted hazard ratio for time to hospital discharge was
1–0.97, P¼0.007) and 0.72 (0.65–0.81, P< .001).
sociations remained mostly significant after multivari-
tment (Table 3). Similarly, we found a higher fre-
n impairment in activities of daily living (Barthel
5 points) based on vitamin D levels, with 11.3%,
nd 18.7% in vitamin D sufficient, insufficient, and
deficient patients, respectively. For severely deficient
the association was significant with an OR of 1.80
1.42–2.28, P<0.001), which remained robust after
nt. In subgroup analysis (Appendix 1, http://links.











ically significant at P< 0.05.modification (P<0.05) with the main diagnosis of
cular diseases, which had an even stronger associ-




# 2016 Wolters Kluwer Health, Inc. All rights reserved.levels with 30-day hospital readmission rate overall,
fferent subgroups (no effect modifications).
actures and Quality of Life in the
Up
found a stepwise increase in reports of falls in the
deficient and severely deficient patients (3.1%, 3.4%,
), yet after adjustment these associations did not
ignificant. Also, the frequency of reported fractures
epend on vitamin D status (P¼0.69).
also observed an increase in reported impairment in
f life (defined by mobility, self-care, usual activity,
omfort, and anxiety/depression) in patients with a
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Copyrightt vitamin D status, except for the dimensions pain/
rt and anxiety/depression. The association between
itamin D deficiency and decreased quality of life
significant after adjustment save for pain/discomfort




























me/A941 and Figures 4 and 5), there was no evidence of
dification (P>0.05).
DISCUSSION
findings of our study including a large and well-
ized cohort of medical inpatients with different dis-
h vitamin D levels measured upon hospital admission
: 1st, we found a high prevalence of>50% of vitamin
ncy with levels below 50 nmol/L and almost 20% of
ad with severe deficiency with levels below 25 nmol/
ccords with findings from a previous study by Thomas
well as data from the Federal Office of Public health in
nd.28 Second, we found strong associations of vitamin
ncy and several patient relevant adverse clinical out-
easured during the hospital stay and after 30 days
mortality, LOS, falls and functional impairment, and
f life. Third, most of these associations remained robust
ltivariate adjustment and within different subgroups






















outcoeral clinical studies have been conducted investigating
n of vitamin D deficiency and different adverse




# 2016 Wolters Kluwer Health, Inc. All rights reserved.,43–45 functional impairment,46,47 higher disease
9–41,48 and increased risk or severity of infec-
,33,43,49–52 However, most of these studies were small
ed to specific patient subgroups. Also, rigorous multi-
djustment for possible confounders was not done in
ies. Although several studies suggest a link between
D deficiency and various adverse outcomes, definite
ns could not be drawn. To our knowledge, our study is
amine associations of vitamin D deficiency and adverse
in a large and unselected patient population with
short-term medical outcomes and is thus able to close
ever, our study is not able to prove causality and to
e question whether vitamin D deficiency contributes
patient outcome or whether it is merely a surrogate of
disease severity, lower exposure to sun, and/or
tion. To address this issue we used multivariate
n analysis including different potential confounders
ge and disease.Most of the observed associations were
till, interventional research is needed to answer
ion whether vitamin D supplementation in the acute
illness in medical inpatients has beneficial effects on
.
min D is also considered as a negative acute-phase
which could explain the observed low levels during
ess and the association between low levels and adverse
such as higher mortality. Several mechanisms may be
   95% CI      Adj. OR 
y mortality by patient subgroups.le for such as a decrease of vitamin D carrier proteins,
conversion of 25(OH)D to 1,25(OH)2D, as well as
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95% CI Adj. HR
FIGURE 2. Predictive value of vitamin D insufficiency and deficiency for time to hospital discharge by patient subgroups.
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95% CI Adj. OR









































95% CI Adj. OR
FIGURE 4. Predictive value of vitamin D insufficiency and deficiency for functional impairment by patient subgroups as measured by the
Barthel index.
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Copyrighttly lower albumin level in vitamin D deficient
5,56 Thus, measuring total serum 25(OH)D may not
ate to assess vitamin D status during acute illness. The
ion of 25(OH)D may be a more accurate representa-
ause it is not influenced by albumin levels and it
s the physiologically important fraction. However,
ent of the bioavailable fraction is technically more
ng.55,57
min D has also been suggested to have antiinflam-
nd antiproliferative properties.4,58 These effects may
thologically explain the increase in adverse out-
ith deficient vitamin D status and call for the sub-
of patients in order to correct impaired vitamin D
However, without interventional data in this patient
n such conclusions may not be warranted. Current
ndations for vitamin D screening and supplement-
based on data regarding the benefits for musculos-
utcomes. Many large observational studies have been
d on the benefits of vitamin D supplementation on
fractures.60,61 Still, even for musculoskeletal health
remaining ambiguity with recent randomized trials
conflicting results.62,63
study has several strengths: we studied a large, well-
ohort with a heterogeneous patient population, thus
the validity of our data in the general population. In
assess impairments in quality of life and activities of
ing we used standardized tools, which furthermore
the comparison of our results. Vitamin D levels were
in a consecutive sample limiting the risk of selection
vertheless, some limitations of our study should be
d. It was a single-center study including Swiss patients
lts may not be generalizable to other countries.
we adjusted for potential confounders, we cannot
the possibility of residual confounding factors influ-
ur results. For example, parathyroid hormone levels
available. Also, there is controversy regarding the best
logy for measuring 25(OH)D. High-performance
romatography is generally considered the gold-stan-
t is more accurate and reliable than the chemilumines-
munoassay we used in our study. However, this
is time and labor intensive and requires expensive
t, thus making it unsuitable to high-capacity clinical
ies.64,65 In addition, we did not have data available on
y of disease which may be an important factor explain-
elationship of low vitamin D levels and adverse out-
ost importantly, as an observational study it is more
is generating and does not address causality.
CONCLUSION
study confirms results from previous studies and
high prevalence of inadequate vitamin D status in
cal inpatient population with strong associations with
adverse medical outcomes and robust results among
medical diagnosis subgroups. High-quality random-
rolled studies are needed to assess whether vitamin D
ntation could improve the course and recovery from
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